Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
192.97
+1.22 (+0.64%)
Official Closing Price
Updated: 4:10 PM EST, Feb 6, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbbVie
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
74
75
Next >
3 Pharmaceutical Stocks to Buy Hand Over Fist in March
March 11, 2024
There are some great companies at attractive prices in the lucrative pharmaceutical space.
Via
The Motley Fool
3 Unstoppable Mega-Cap Stocks That Every Investor Should Own in 2024
March 09, 2024
Dive into the world of three unstoppable mega-cap stocks leading the charge amidst the bullishness in the market.
Via
InvestorPlace
The AI Race Gets Litigious
March 09, 2024
We've also got a look at the role of patents in pharmaceuticals and the "patent cliff" looming over the next decade.
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Have $2,500? 2 Superior Growth Stocks to Buy in 2024
March 09, 2024
These businesses can pack a punch in your portfolio over the long run.
Via
The Motley Fool
FDA Conditionally Approves Expanded Use Of BeiGene's Combination Drug For Certain Type Of Blood Cancer
March 08, 2024
FDA grants accelerated approval to BeiGene's Brukinsa for relapsed/refractory follicular lymphoma. Approved in combination with Roche's Gazyva after two or more lines of therapy. Brukinsa, priced at...
Via
Benzinga
Exposures
Product Safety
Is AbbVie Stock a Buy Now?
February 29, 2024
Some would say the growth story is over, but that view might be a bit myopic.
Via
The Motley Fool
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
February 28, 2024
Via
Benzinga
AbbVie Inc. (NYSE: ABBV) Records 52-Week High Friday Morning
February 16, 2024
Via
Investor Brand Network
3 Dividend Aristocrats With the Largest 10-Year Dividend Growth Rates
March 06, 2024
These three dividend stocks have proved themselves to be among the best Dividend Aristocrats to buy for high-growth returns.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
March 06, 2024
Via
Benzinga
The Top 7 Dividend Stocks to Buy in March 2024
March 06, 2024
Bet on these top dividend stocks to buy for a resilient income flow and steady market gains, offering excellent balance.
Via
InvestorPlace
Secure Your Future: 7 Dividend Kings with Solid Growth Potential
March 04, 2024
Here are seven dividend kings that manage to deliver market-beating stock price growth in addition to their reliable, growing dividends.
Via
InvestorPlace
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
March 01, 2024
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
AbbVie Stock Clears Key Benchmark, Hitting 80-Plus RS Rating
February 14, 2024
A Relative Strength Rating upgrade for AbbVie shows improving technical performance.
Via
Investor's Business Daily
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
March 05, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:OCEA),(NASDAQ:LVTX),(NYSE:MRK),(NYSE:ABBV) EQNX::TICKER_END
Via
FinancialNewsMedia
The Hot List: 3 AI Stocks Worth Buying on Weakness
March 01, 2024
Firms using AI directly can be great picks for long-term investors, such as these three AI stocks to buy on weakness.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Better Dividend Growth Stock: AbbVie or Amgen?
February 29, 2024
A strong case can be made for owning both of these dividend growth stocks. But one of them is the better buy.
Via
The Motley Fool
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
March 05, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Healis Therapeutics' asset CKDB-501A shares Phase III topline results for glabellar injections from CKD Bio in South Korea
February 27, 2024
From
Healis Therapeutics
Via
GlobeNewswire
3 Magnificent Dividend Growth Stocks to Buy Now and Hold for at Least a Decade
February 27, 2024
These stocks don't offer the highest yields, but their payouts are growing fast.
Via
The Motley Fool
Why Is Generic Drugs Player Teva Pharma Stock Trading Higher Today?
February 26, 2024
FDA-approved Simlandi (adalimumab-ryvk): a high-concentration biosimilar to Humira for rheumatoid arthritis, psoriasis, and more.
Via
Benzinga
3 Dividend Stocks That Are No-Brainer Buys Right Now
February 24, 2024
These stocks check off multiple boxes for investors.
Via
The Motley Fool
Is AbbVie Stock a Buy Now?
February 22, 2024
Management pivoting a $300 billion company as quickly as it has is nothing short of remarkable.
Via
The Motley Fool
5 Forever Dividend Stocks to Build Your Portfolio
February 20, 2024
These five stocks are high quality and reliable.
Via
The Motley Fool
3 Magnificent Growth Stocks to Buy Right Now
February 19, 2024
These stocks share at least two common denominators: a biopharmaceutical focus and great long-term prospects.
Via
The Motley Fool
3 Cash Cows to Boost Your Confidence During the February Chill
February 18, 2024
The market can be a tricky place. Bet on these cash cow stocks to help restore confidence and extract steady returns.
Via
InvestorPlace
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
February 15, 2024
EQNX::TICKER_START (NASDAQ:TNXP),(NYSE:PFE),(NYSE:LLY),(NYSE:ABBV),(NYSE:MRK) EQNX::TICKER_END
Via
FinancialNewsMedia
Beyond Nvidia: How To Navigate Investing In Your 40s — Insights From Reddit
February 14, 2024
A Reddit user reached out to the community seeking advice beyond the hunt for the "next NVIDIA Corp." Here's a sample of the responses.
Via
Benzinga
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
February 15, 2024
From
FN Media Group LLC
Via
GlobeNewswire
The 7 Best Momentum Stocks You Can Purchase Today
February 12, 2024
If you’re looking for hot opportunities in the market, here are just a few of the best momentum stocks to buy today.
Via
InvestorPlace
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
74
75
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.